Depression occurs in people with MS approximately 2-3 times more often than in the general population, and is less likely to subside without effective treatment. Depression in people with MS has been linked to poorer outcomes, including lower quality of life and employment, greater difficulties with thinking and feelings of helplessness, poorer relationships with family and friends and greater difficulty with self-care. Despite this, international research shows that detection of depressive symptoms is sub-optimal, missing up to 36% of people with MS and depression. Once depressive symptoms are detected, only about 46% of people are referred for treatment. Furthermore, up to 65% of people receiving treatment still report moderate-to-severe depression, suggesting treatment requires greater monitoring and adjustment.
Although clearly there is a need for better detection, referral and treatment of depressive symptoms, it is unclear what the best strategy is to improve current practice. This study aims to investigate 1) how depression is assessed and managed by healthcare professionals in MS specialist clinics, and 2) what barriers exist to assessing and treating depression for healthcare professionals and people with MS. Dr Lisa Grech and her team will interview neurologists, nurses and people with MS to answer research questions. This will lead to a better understanding of the issues and will inform further proposals to assess these issues in a larger national sample of MS healthcare professionals and people with MS. The results of this will inform recommendations to improve the identification and treatment of depression in people with MS.
Updated: 21 January, 2020
Laboratory research that investigates scientific theories behind the possible causes, disease progression, ways to diagnose and better treat MS.
Research that builds on fundamental scientific research to develop new therapies, medical procedures or diagnostics and advances it closer to the clinic.
Clinical research is the culmination of fundamental and translational research turning those research discoveries into treatments and interventions for people with MS.